Everbright
Asia, Hong Kong Island, Hong Kong, Wan Chai'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Everbright is China’s cross-border investment and asset management company.
Investor Profile
Everbright has made 11 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (36%)
- Series C (18%)
- Private Equity (18%)
- Series D (9%)
- Series Unknown (9%)
- Series B (9%)
Country Focus
- China (73%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- United States (18%)
- Hong Kong (9%)
Industry Focus
- Health Care
- Biotechnology
- Manufacturing
- Medical
- Oncology
- Pharmaceutical
- Consulting
- Information Services
- Information Technology
- It Management
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
